Regulus Therapeutics CEO Joseph Hagan's 2019 pay slips 14% to $2M
Regulus Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Regulus Therapeutics reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, four executives at Regulus Therapeutics received on average a compensation package of $858K, a 46% decrease compared to previous year.
Average pay of disclosed executives at Regulus Therapeutics
Joseph P. Hagan, Chief Executive Officer, received $2M in total, which decreased by 14% compared to 2018. 43% of Hagan's compensation, or $861K, was in non-equity incentive plan. Hagan also received $540K in option awards, $536K in salary, $69K in stock awards, as well as $8.6K in other compensation.
Christopher R. Aker, General Counsel, received a compensation package of $788K. 37% of the compensation package, or $290K, was in salary.
Daniel R. Chevallard, Chief Financial Officer, earned $328K in 2019, a 67% decrease compared to previous year.
Cris Calsada, Chief Financial Officer, received $303K in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2020.